Physician profile
Daniel Scott Brickman
NPI 1760636450
$1,346.66
in general payments reported to CMS, 2019-2025
12 companies · $959 in 2025
The $959 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.85 · 2022: $259 · 2023: $47.71 · 2024: $62.96 · 2025: $959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861 · Long Term Medical Supply Or Device Loan: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.74 |
| Long Term Medical Supply Or Device Loan | $209.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $288.85 | 2022-2025 | |
| Integra Lifesciences Corporation | $255.34 | 2025 | Integra, Cytal, Micromatrix |
| Sanara Medtech INC. | $210.89 | 2025 | Celleraterx |
| Kls-Martin L.P. | $192.31 | 2025 | |
| Medtronic, INC. | $136.98 | 2022 | |
| Depuy Synthes Sales INC. | $117.05 | 2025 | Na, Vivigen Mis Delivery System |
| Biotissue Holdings INC. | $62.96 | 2024 | |
| Merck Sharp & Dohme LLC | $36.05 | 2025 | Keytruda |
| Solventum Corporation | $14.61 | 2025 | 3m Cavilon, V.A.C. Veraflo Cleanse Choice, Prevena |
| Welch Allyn | $14.11 | 2021 | |
| Stryker Corporation | $13.77 | 2025 | Audion Et Dilation System |
| Forte Bio-Pharma LLC | $3.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Brickman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.